Search

AstraZeneca PLC

Closed

SectorHealthcare

169.97 0.81

Overview

Share price change

24h

Current

Min

167.08

Max

173.13

Key metrics

By Trading Economics

Income

1.6B

3.9B

Sales

-215M

15B

P/E

Sector Avg

25.428

62.58

EPS

1.29

Dividend yield

1.89

Profit margin

25.602

Employees

96,100

EBITDA

1.1B

5.7B

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+23.7% upside

Dividends

By Acuity

Dividend yield

Sector Avg

1.89%

2.19%

Next Dividend date

8 Sept 2026

Next Ex Dividend date

6 Aug 2026

Market Stats

By TradingEconomics

Market Cap

-29B

262B

Previous open

169.16

Previous close

169.97

News Sentiment

By Acuity

45%

55%

135 / 340 Healthcare

AstraZeneca PLC Chart

Past performance is not a reliable indicator of future results.

Related News

27 Jul 2026, 23:56 UTC

Correlated Moves
News

Diamondback Energy gained during after-market hours, buoyed by strong revenue growth and a favorable market position, with shares peaking above Monday's close.

27 Jul 2026, 23:51 UTC

News
Event

UDR Inc reported second-quarter net income of $69.035 million. Shares declined in after-market trading amid concerns over flat revenue and rising costs.

27 Jul 2026, 23:51 UTC

News

L3Harris Technologies has secured Pentagon agreements to boost missile defense production, but shares are trading lower in after-market hours.

27 Jul 2026, 23:51 UTC

News
Social Media

Tesla Inc shares declined in after-market trading, continuing a trend of lower closes over the past four sessions amid analyst caution following its Q2 performance.

27 Jul 2026, 23:51 UTC

News

Rivian shares rise in after-market trading as analysts upgrade outlook and boost price target ahead of earnings report on July 30.

27 Jul 2026, 23:51 UTC

News

Cincinnati Financial Corp shares fell in after-market hours following second-quarter results that missed expectations for EPS and revenue. Earlier in the session, shares briefly rose.

27 Jul 2026, 23:51 UTC

News
Social Media

Cadence Design Systems shares are higher in after-market trading following strong Q2 results and an increase in full-year revenue guidance to $6.26 billion to $6.34 billion.

27 Jul 2026, 23:51 UTC

News
Social Media

Microstrategy shares declined in after-market hours following Peter Schiff's criticism of the company's Bitcoin yield, which fell significantly in recent months.

27 Jul 2026, 23:51 UTC

News

Accenture PLC shares are lower in after-market hours despite a $2 billion share repurchase program and a quarterly dividend announcement.

27 Jul 2026, 23:51 UTC

News

NIO shares rose in after-market trading, building on regular-session gains. Options activity showed bullish sentiment, with calls outpacing puts significantly.

27 Jul 2026, 23:51 UTC

News
Social Media
Correlated Moves

Micron Technology Inc shares declined in after-market trading following a report raising concerns about the company's growth potential and future demand for memory chips.

27 Jul 2026, 23:51 UTC

News
Social Media

Amkor Technology's shares declined in after-market trading following weaker-than-expected third-quarter revenue guidance despite strong second-quarter results and earnings.

27 Jul 2026, 23:42 UTC

News
Correlated Moves

Bitcoin is trading lower as easing geopolitical tensions reduce demand for safe-haven assets. Ethereum also declines, reflecting its correlation with Bitcoin's market movements.

27 Jul 2026, 23:42 UTC

Correlated Moves
News

Bitcoin is trading lower as easing geopolitical tensions reduce demand for safe-haven assets. Ethereum also declines amid similar market dynamics.

27 Jul 2026, 23:41 UTC

News
Correlated Moves

NBT Bancorp shares are higher in after-market trading following second-quarter results, which included net income of $53 million and a dividend increase to $0.40 per share.

27 Jul 2026, 23:41 UTC

News
Social Media

Brown & Brown Inc reported second-quarter revenues of $1.68 billion, missing expectations. Shares are trading lower in after-market hours following the mixed results.

27 Jul 2026, 23:41 UTC

News

OPKO Health reported second-quarter revenues of $163.5 million, surpassing expectations. The company also raised its full-year sales guidance, boosting shares in after-market trading.

27 Jul 2026, 23:41 UTC

News

International Paper shares are higher in after-market trading as CEO Andy Silvernail prepares to present at the Jefferies 2026 Industrials Conference on September 10.

27 Jul 2026, 23:41 UTC

News

Oil prices are higher in after-market hours, supported by reduced supply disruption concerns from the Middle East and gains in European markets.

27 Jul 2026, 23:31 UTC

News

Northwest Bancshares reported second-quarter adjusted EPS of $0.37 and revenue of $181.2 million, exceeding expectations. Shares are trading higher in after-market hours.

27 Jul 2026, 23:31 UTC

News
Social Media

Johnson & Johnson shares are higher in after-market trading following a proposed $5.5 billion settlement for ovarian talc litigation involving about 76,000 claims.

27 Jul 2026, 23:31 UTC

News
Social Media

ServiceNow shares rose during after-market hours as software stocks recovered. CEO Bill McDermott reported no slowdown in demand amid mixed social media sentiment on AI impacts.

27 Jul 2026, 23:26 UTC

News

Nucor Corporation reported second-quarter earnings of $1.16 billion, exceeding estimates. Shares are trading higher in after-market hours following the strong results.

27 Jul 2026, 23:16 UTC

News
Social Media

Intel Corp shares are lower in after-market hours following a $2.1 billion loss, despite a 25% revenue increase to $16.1 billion in Q2.

27 Jul 2026, 23:16 UTC

News

Dell Technologies Inc. shares are lower in after-market hours, continuing a trend from the previous three sessions amid a focus on AI-optimized infrastructure solutions.

27 Jul 2026, 23:16 UTC

News

Zoetis shares are lower in after-market hours following a class action lawsuit alleging securities fraud and reduced profit guidance to between $6.85 and $7.00 per share.

27 Jul 2026, 23:11 UTC

News

Albertsons Companies Inc shares are lower in after-market hours amid an investigation into potential securities law violations and a Q1 EPS miss of $0.42.

27 Jul 2026, 23:02 UTC

News
Social Media

Welltower reported strong Q2 results, raising full-year FFO guidance and increasing its dividend. Shares are trading higher in after-market hours.

27 Jul 2026, 23:02 UTC

News
Social Media

Sanmina Corp shares are lower in after-market trading despite strong Q3 results, as Q4 guidance fell short of consensus estimates.

27 Jul 2026, 23:02 UTC

News

GoPro Inc. will release its Q2 financial results on August 10, 2026, contributing to a higher after-market price as investors anticipate insights.

Peer Comparison

Price change

AstraZeneca PLC Forecast

Price Target

By TipRanks

23.7% upside

12 Months Forecast

Average 209.37 USD  23.7%

High 251.221 USD

Low 150.201 USD

Based on 16 Wall Street analysts offering 12 month price targets forAstraZeneca PLC - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

16 ratings

13

Buy

2

Hold

1

Sell

Sentiment

By Acuity

135 / 340 Healthcare

News Sentiment

Bullish Evidence

Volatility

Above average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About AstraZeneca PLC

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; BenevolentAI for drug discovery for systemic lupus erythematosus; Lunit for developing AI-Powered Digital Pathology Risk Assessment Tools for NSCLC; and Absci Corporation for AI-driven drug discovery against an oncology target. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.
help-icon Live chat